WEBVTT - Johnson & Johnson's CEO on the Newest Vaccine

0:00:04.480 --> 0:00:08.960
<v Speaker 1>Welcome to Prognosis. I'm Laura Carlson. It's day three hundred

0:00:09.000 --> 0:00:13.000
<v Speaker 1>and fifty two since coronavirus was declared a global pandemic.

0:00:13.560 --> 0:00:18.599
<v Speaker 1>Today's main story Johnson and Johnson's one shot vaccine has

0:00:18.640 --> 0:00:23.360
<v Speaker 1>been approved by regulators. We asked the CEO how he

0:00:23.520 --> 0:00:28.560
<v Speaker 1>plans to increase supply to get one million people vaccinated

0:00:29.040 --> 0:00:40.559
<v Speaker 1>by summer. But first, here's what happened in virus News today.

0:00:45.960 --> 0:00:50.599
<v Speaker 1>The Biden administration has already begun shipping almost four million

0:00:50.680 --> 0:00:56.040
<v Speaker 1>doses of Johnson and Johnson's COVID nineteen vaccine on Sunday.

0:00:56.320 --> 0:01:00.160
<v Speaker 1>The Centers for Disease Control and Prevention formally recommend at

0:01:00.160 --> 0:01:04.240
<v Speaker 1>the shot for adults. Now that all regulatory hurdles have

0:01:04.400 --> 0:01:09.080
<v Speaker 1>been cleared, providers can finally start administering doses of the

0:01:09.160 --> 0:01:13.760
<v Speaker 1>first one shot vaccine. The first deliveries of the vaccine

0:01:13.880 --> 0:01:17.800
<v Speaker 1>will arrive as early as Tuesday. That's according to senior

0:01:17.840 --> 0:01:23.040
<v Speaker 1>administration officials who held a briefing call on condition of anonymity.

0:01:23.240 --> 0:01:26.200
<v Speaker 1>The officials said the shots will be shipped through every

0:01:26.240 --> 0:01:30.520
<v Speaker 1>distribution channel, including to states on a per capita basis,

0:01:30.880 --> 0:01:35.000
<v Speaker 1>as well as directly to pharmacies. And community health centers.

0:01:36.200 --> 0:01:39.560
<v Speaker 1>The UK is trying to trace a person infected with

0:01:39.600 --> 0:01:44.800
<v Speaker 1>the Brazilian variant of the coronavirus. Six cases of the mutation,

0:01:45.120 --> 0:01:48.800
<v Speaker 1>which originated in the Amazonian city of Manaus, have been

0:01:48.800 --> 0:01:53.640
<v Speaker 1>detected in the UK, while five have been found. The

0:01:53.760 --> 0:01:57.920
<v Speaker 1>identity of the final patient is still unknown because they

0:01:57.960 --> 0:02:01.840
<v Speaker 1>fail to complete a test register ration card, leaving health

0:02:01.880 --> 0:02:06.640
<v Speaker 1>officials without the information needed to find them. Over twenty

0:02:06.640 --> 0:02:10.359
<v Speaker 1>million people in the UK have now been vaccinated, according

0:02:10.400 --> 0:02:17.000
<v Speaker 1>to Britain's Health Minister Matt Hancock. Finally, Russians are skeptical

0:02:17.200 --> 0:02:22.160
<v Speaker 1>of the locally developed spot NICK five vaccine. Some of

0:02:22.240 --> 0:02:25.960
<v Speaker 1>Russians said they wouldn't take the injections the most since

0:02:25.960 --> 0:02:30.280
<v Speaker 1>the question was introduced in August. That's according to a

0:02:30.320 --> 0:02:36.160
<v Speaker 1>February poll by the independent Lovada Center. The responses highlight

0:02:36.240 --> 0:02:40.560
<v Speaker 1>problems with the inoculations rollout despite evidence that it is

0:02:40.600 --> 0:02:53.560
<v Speaker 1>safe and effective. And now for today's main story. Now

0:02:53.600 --> 0:02:57.440
<v Speaker 1>that Johnson and Johnson's COVID nineteen vaccine has been cleared

0:02:57.440 --> 0:03:01.680
<v Speaker 1>by regulators, the company needs to ramp up doses fast.

0:03:02.600 --> 0:03:06.600
<v Speaker 1>J and J is looking for manufacturing partnerships to increase supply.

0:03:07.360 --> 0:03:10.800
<v Speaker 1>The company wants to speed up its timeline to immunize

0:03:10.919 --> 0:03:14.600
<v Speaker 1>twenty million Americans by the end of the month and

0:03:14.800 --> 0:03:19.440
<v Speaker 1>one million by the end of June. Riley Griffin interviewed

0:03:19.440 --> 0:03:24.000
<v Speaker 1>the company's chief executive officer, Alex Gorsky. I spoke to

0:03:24.040 --> 0:03:35.800
<v Speaker 1>her about what else she learned from their interview. So

0:03:36.320 --> 0:03:40.080
<v Speaker 1>you recently spoke to the CEO for Johnson and Johnson,

0:03:40.160 --> 0:03:44.600
<v Speaker 1>Alex Gorski, about the recent authorization of their single shot

0:03:44.600 --> 0:03:48.480
<v Speaker 1>COVID nineteen vaccine in the US. So tell me what

0:03:48.680 --> 0:03:53.040
<v Speaker 1>does he see as the role for a one dose vaccine,

0:03:53.320 --> 0:03:56.960
<v Speaker 1>either in terms of the US vaccine campaign or or

0:03:57.040 --> 0:04:00.280
<v Speaker 1>more globally. Alex Scorski said, a one shot back scene

0:04:00.320 --> 0:04:03.160
<v Speaker 1>is going to be a critical tool in reaching populations

0:04:03.200 --> 0:04:07.120
<v Speaker 1>that interface less frequently with the health care system, like

0:04:07.360 --> 0:04:11.000
<v Speaker 1>US top infectious disease specialist Anthony Fauci. He discussed it

0:04:11.160 --> 0:04:14.839
<v Speaker 1>particularly as a boon to rural communities in the US.

0:04:15.000 --> 0:04:18.760
<v Speaker 1>The impact that a single dose vaccine I think can

0:04:18.880 --> 0:04:23.400
<v Speaker 1>have on access and distribution around the world just can't

0:04:23.440 --> 0:04:28.279
<v Speaker 1>be overstated. We have now three vaccines that have been approved,

0:04:28.320 --> 0:04:31.320
<v Speaker 1>we have dozens more that are in development. All these

0:04:31.440 --> 0:04:36.040
<v Speaker 1>vaccines have been shown to be incredibly safe, incredibly effective.

0:04:36.480 --> 0:04:40.880
<v Speaker 1>Now that we have that kind of a profile, with

0:04:41.040 --> 0:04:46.520
<v Speaker 1>a single dose that requires standard refrigeration um as you

0:04:46.520 --> 0:04:50.560
<v Speaker 1>would expect with very commonly used vaccines, and not for

0:04:50.640 --> 0:04:56.279
<v Speaker 1>profit price, we think that that will significantly reduce some

0:04:56.360 --> 0:04:59.480
<v Speaker 1>of the administrative some of the logistical challenges you know,

0:04:59.520 --> 0:05:05.480
<v Speaker 1>associate add with the actual vaccine administration. Administering a single

0:05:05.560 --> 0:05:08.359
<v Speaker 1>dose is going to be fairly cost effective for health

0:05:08.400 --> 0:05:11.760
<v Speaker 1>systems to a one and done vaccine. Doesn't require the

0:05:11.839 --> 0:05:15.160
<v Speaker 1>time and the resources needed to orchestrate and schedule out

0:05:15.520 --> 0:05:20.240
<v Speaker 1>a second dose. Administration and administering shots cost money, so

0:05:20.279 --> 0:05:23.120
<v Speaker 1>this will certainly lessen the burden on health systems around

0:05:23.160 --> 0:05:27.760
<v Speaker 1>the country. Finally, the Johnson and Johnson CEO mentioned that

0:05:27.920 --> 0:05:30.640
<v Speaker 1>price point here is a critical factor and will be

0:05:30.720 --> 0:05:34.320
<v Speaker 1>important at global scale. Jange is offering the shot on

0:05:34.360 --> 0:05:37.479
<v Speaker 1>a not for profit basis, which means less than ten

0:05:37.520 --> 0:05:41.240
<v Speaker 1>dollars per regiment. Now compare that Defiser and bion Tech,

0:05:41.839 --> 0:05:44.640
<v Speaker 1>which are asking in the US thirty nine per regiment,

0:05:45.040 --> 0:05:48.720
<v Speaker 1>or Maderna at thirty three per regiment. That's going to

0:05:48.880 --> 0:05:53.200
<v Speaker 1>create a more affordable option globally, and with the logistical

0:05:53.279 --> 0:05:55.760
<v Speaker 1>convenience to boot. You can see it as the vaccine

0:05:55.760 --> 0:05:59.800
<v Speaker 1>of choice for many and low in middle income countries. So,

0:06:00.400 --> 0:06:04.840
<v Speaker 1>given that jane J has now received emergency use authorization

0:06:04.880 --> 0:06:08.560
<v Speaker 1>for its vaccine in the US, what does the pace

0:06:08.640 --> 0:06:13.640
<v Speaker 1>of production look like for j and J moving forward. Yeah,

0:06:13.640 --> 0:06:15.920
<v Speaker 1>so jane J is going to deliver three point nine

0:06:15.920 --> 0:06:18.880
<v Speaker 1>million doses of its one shot vaccine within the next

0:06:19.080 --> 0:06:22.520
<v Speaker 1>twenty four to forty eight hours, Gorsky said, And the

0:06:22.520 --> 0:06:25.599
<v Speaker 1>company wants to speed up its timeline actually of supplying

0:06:25.720 --> 0:06:29.000
<v Speaker 1>enough vaccines to immunize twenty million Americans by the end

0:06:29.000 --> 0:06:31.560
<v Speaker 1>of the month and a total of a hundred million

0:06:31.600 --> 0:06:34.560
<v Speaker 1>Americans by the end of June. How are they going

0:06:34.600 --> 0:06:36.640
<v Speaker 1>to do that, Well, they're going to focus on two

0:06:36.720 --> 0:06:41.640
<v Speaker 1>different parts of the production process. First is its capacity

0:06:41.680 --> 0:06:44.960
<v Speaker 1>for making a live cold virus called an adena virus

0:06:44.960 --> 0:06:47.719
<v Speaker 1>that's used in the shot to trigger an immune response

0:06:47.760 --> 0:06:51.600
<v Speaker 1>that fights off infection. They actually have to create proteins

0:06:51.680 --> 0:06:53.960
<v Speaker 1>and that takes some time to grow, so they want

0:06:54.000 --> 0:06:57.120
<v Speaker 1>to build out capacity there. Another space they want to

0:06:57.120 --> 0:07:01.040
<v Speaker 1>augment is the company's phil finished process US. That's the

0:07:01.040 --> 0:07:04.520
<v Speaker 1>facilities where the drug substance at the very final part

0:07:04.520 --> 0:07:08.560
<v Speaker 1>of the production process are actually placed inside files. Phil

0:07:08.600 --> 0:07:12.240
<v Speaker 1>finished capacity is fairly limited in this country and beyond,

0:07:12.360 --> 0:07:14.760
<v Speaker 1>and as a result, the company is looking to increase

0:07:14.840 --> 0:07:17.360
<v Speaker 1>it in the future. I mean, I don't believe that

0:07:17.520 --> 0:07:20.640
<v Speaker 1>there's ever been a time in history to see that

0:07:20.680 --> 0:07:25.679
<v Speaker 1>many actual doses produced in that period of time. Based

0:07:25.720 --> 0:07:27.720
<v Speaker 1>upon the work that we've already done, as you noted,

0:07:28.000 --> 0:07:30.240
<v Speaker 1>we're getting at three point nine literally within the next

0:07:30.920 --> 0:07:33.800
<v Speaker 1>forty eight hours. And what's really important in this riley

0:07:33.880 --> 0:07:39.200
<v Speaker 1>is that those three point nine million doses are regiments also,

0:07:39.720 --> 0:07:42.240
<v Speaker 1>and so that means three point nine million more people

0:07:42.520 --> 0:07:47.160
<v Speaker 1>during the United States will be vaccinated. We're also simultaneously

0:07:47.240 --> 0:07:51.440
<v Speaker 1>going through the regulatory approval process for our other manufacturing facilities.

0:07:51.600 --> 0:07:53.520
<v Speaker 1>Over the course of March, you'll see a ramp up

0:07:53.520 --> 0:07:56.120
<v Speaker 1>to twenty million doses and then it will continue to

0:07:56.160 --> 0:07:59.080
<v Speaker 1>wrap up the way that we just talked about by

0:07:59.160 --> 0:08:02.200
<v Speaker 1>June to a hundred billion doses. And and we are

0:08:02.240 --> 0:08:07.280
<v Speaker 1>doing everything we can, partnering um with the United States

0:08:07.320 --> 0:08:11.400
<v Speaker 1>government and other external manufacturers to see what we can

0:08:11.440 --> 0:08:14.880
<v Speaker 1>do to accelerate an increase that number as well, so

0:08:14.960 --> 0:08:18.240
<v Speaker 1>that uh in our goal consystem from the very beginning

0:08:18.280 --> 0:08:21.120
<v Speaker 1>is to achieve almost a billion doses by the end.

0:08:22.240 --> 0:08:25.960
<v Speaker 1>We actually also heard from a Biden administration official today

0:08:26.080 --> 0:08:29.000
<v Speaker 1>suggesting that distribution and delivery are going to be a

0:08:29.040 --> 0:08:32.840
<v Speaker 1>bit uneven across these early first weeks of March, but

0:08:33.520 --> 0:08:35.880
<v Speaker 1>we'll see more supply in the back half of the month,

0:08:35.960 --> 0:08:38.480
<v Speaker 1>and it ramp up even further as we make it

0:08:38.600 --> 0:08:41.960
<v Speaker 1>past March. You know, at this point, Riley, there are

0:08:42.000 --> 0:08:45.800
<v Speaker 1>several COVID nineteen vaccines authorized for use in the US,

0:08:46.000 --> 0:08:49.679
<v Speaker 1>Johnson and Johnson's, of course, alongside now what's available from

0:08:49.679 --> 0:08:52.840
<v Speaker 1>Finzer and Maderna. What do you think it's important for

0:08:52.880 --> 0:08:56.960
<v Speaker 1>Americans to know as more people confront whether to get

0:08:56.960 --> 0:09:01.079
<v Speaker 1>the vaccine and indeed which vaccine to it. A lot

0:09:01.120 --> 0:09:04.520
<v Speaker 1>of our readers are listeners, and the generally the public

0:09:04.640 --> 0:09:08.160
<v Speaker 1>are looking at the data and trying to compare results

0:09:08.160 --> 0:09:11.160
<v Speaker 1>out of clinical trials, and I think it's important for

0:09:11.200 --> 0:09:15.480
<v Speaker 1>them to know that you can't have a apples to

0:09:15.600 --> 0:09:20.000
<v Speaker 1>apples comparison here. These clinical trials were conducted at different

0:09:20.080 --> 0:09:22.599
<v Speaker 1>parts of the course of the pandemic, and J and

0:09:22.679 --> 0:09:27.720
<v Speaker 1>J IS notably was really at peak infections around the world.

0:09:28.360 --> 0:09:31.800
<v Speaker 1>It's actually the largest COVID nineteen vaccine trial to date,

0:09:31.920 --> 0:09:35.080
<v Speaker 1>and they had plenty of sites here in the US,

0:09:35.160 --> 0:09:39.760
<v Speaker 1>of course, but also in places like Brazil and in

0:09:40.480 --> 0:09:45.240
<v Speaker 1>South Africa where more transmissible virus variants have really dominated.

0:09:45.880 --> 0:09:50.680
<v Speaker 1>I think what we've been particularly pleased with is that

0:09:50.720 --> 0:09:54.960
<v Speaker 1>when you consider that our trial was done really at

0:09:55.240 --> 0:09:58.000
<v Speaker 1>likely the most one of the most challenging times of

0:09:58.040 --> 0:10:01.240
<v Speaker 1>this pandemic, so are are faced a clinical trial started

0:10:01.240 --> 0:10:05.960
<v Speaker 1>in September October that did not finish until it's still

0:10:05.960 --> 0:10:09.200
<v Speaker 1>not finished, we're ongoing, but was measured through January, and

0:10:09.240 --> 0:10:12.040
<v Speaker 1>if you look at the incidents rates around the world,

0:10:12.679 --> 0:10:15.400
<v Speaker 1>they were at some of their highest levels. Number two,

0:10:15.840 --> 0:10:18.280
<v Speaker 1>our our trial is conducted on a global basis, so

0:10:18.679 --> 0:10:22.880
<v Speaker 1>approximately our patients were in Latin America, I believe around

0:10:22.920 --> 0:10:27.520
<v Speaker 1>for we're in the United States, were in South Africa,

0:10:28.080 --> 0:10:32.840
<v Speaker 1>and in South Africa. Over the patients that were infected

0:10:33.440 --> 0:10:37.920
<v Speaker 1>had the South African the one one variant, and we

0:10:37.960 --> 0:10:41.120
<v Speaker 1>saw a significant number with the P two variant in

0:10:41.160 --> 0:10:45.720
<v Speaker 1>northern Brazil. And so at a time when the infection

0:10:45.800 --> 0:10:51.280
<v Speaker 1>rates were at among the highest, when we were seeing

0:10:51.320 --> 0:10:55.000
<v Speaker 1>these new strains at a very significant level, we were

0:10:55.120 --> 0:11:00.200
<v Speaker 1>still able to demonstrate very strong overall efficacy rates, but

0:11:00.240 --> 0:11:04.640
<v Speaker 1>particularly in the severe cases where we saw efficacy rates

0:11:05.080 --> 0:11:10.000
<v Speaker 1>higher than and we saw a pent of the time

0:11:10.520 --> 0:11:13.280
<v Speaker 1>we were effective in keeping patients out of the hospital

0:11:13.400 --> 0:11:16.000
<v Speaker 1>and keep them from dying, which we think are two

0:11:16.000 --> 0:11:20.240
<v Speaker 1>of the more and most important data points for patients,

0:11:20.240 --> 0:11:24.559
<v Speaker 1>for consumers, for health care systems to understand. The most

0:11:24.640 --> 0:11:29.320
<v Speaker 1>important point to note again is as a public health tool,

0:11:29.520 --> 0:11:32.920
<v Speaker 1>Jane Jay's vaccine serves its purpose. It keeps people from

0:11:32.920 --> 0:11:37.040
<v Speaker 1>getting very sick and was ad effective in keeping people

0:11:37.120 --> 0:11:41.040
<v Speaker 1>out of the hospital and from dying. That is critical

0:11:41.240 --> 0:11:44.240
<v Speaker 1>because that reduces the strain on the health system. I

0:11:44.280 --> 0:11:47.640
<v Speaker 1>spoke actually with Michelle Williams and epidemiologists and the dean

0:11:47.840 --> 0:11:51.160
<v Speaker 1>of the Harvard Hands School of Public Health, and she said, quote,

0:11:51.160 --> 0:11:53.640
<v Speaker 1>this is not the time to be quibbling over decimal

0:11:53.679 --> 0:11:57.280
<v Speaker 1>places where the levels of efficacy that we're seeing, and

0:11:57.320 --> 0:12:00.720
<v Speaker 1>her message was really clear. Vaccines as a public health

0:12:00.760 --> 0:12:04.280
<v Speaker 1>tool are meant to keep people from getting sick, becoming hospitalized,

0:12:04.320 --> 0:12:07.720
<v Speaker 1>and overwhelming the healthcare system. And that's precisely what Jane

0:12:07.800 --> 0:12:16.320
<v Speaker 1>Jay's vaccine does. That was Riley Griffin, and that's it

0:12:16.360 --> 0:12:18.800
<v Speaker 1>for our show today for coverage of the outbreak from

0:12:18.800 --> 0:12:23.000
<v Speaker 1>one and twenty bureaus around the world. Visit bloomberg dot com,

0:12:23.000 --> 0:12:27.000
<v Speaker 1>slash Coronavirus, and if you like the show, please leave

0:12:27.080 --> 0:12:30.400
<v Speaker 1>us a review and a rating on Apple Podcasts or Spotify.

0:12:30.960 --> 0:12:33.360
<v Speaker 1>It's the best way to help more listeners find our

0:12:33.360 --> 0:12:37.800
<v Speaker 1>global reporting. The Prognosis Daily edition is produced by Tophor

0:12:37.840 --> 0:12:42.760
<v Speaker 1>foreheads Magnus Henrickson and me Laura Carlson. Today's main story

0:12:43.040 --> 0:12:46.800
<v Speaker 1>was reported by Riley Griffin. Original music by Leo Sidrin.

0:12:47.200 --> 0:12:51.360
<v Speaker 1>Our editors are Rick Shine and Francesca Levi. Francesco Levi

0:12:51.600 --> 0:12:54.960
<v Speaker 1>is Bloomberg's head of podcasts. Thanks for listening.